NO20034538D0 - Anvendelsen av enantiomer ren escitalopram - Google Patents
Anvendelsen av enantiomer ren escitalopramInfo
- Publication number
- NO20034538D0 NO20034538D0 NO20034538A NO20034538A NO20034538D0 NO 20034538 D0 NO20034538 D0 NO 20034538D0 NO 20034538 A NO20034538 A NO 20034538A NO 20034538 A NO20034538 A NO 20034538A NO 20034538 D0 NO20034538 D0 NO 20034538D0
- Authority
- NO
- Norway
- Prior art keywords
- enantiomeric pure
- pure escitalopram
- escitalopram
- enantiomeric
- pure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200100684 | 2001-05-01 | ||
PCT/DK2002/000281 WO2002087566A1 (en) | 2001-05-01 | 2002-05-01 | The use of enantiomeric pure escitalopram |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20034538D0 true NO20034538D0 (no) | 2003-10-09 |
NO20034538L NO20034538L (no) | 2003-10-09 |
Family
ID=8160464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034538A NO20034538L (no) | 2001-05-01 | 2003-10-09 | Anvendelsen av enantiomer ren escitalopram |
Country Status (25)
Country | Link |
---|---|
US (7) | US20040198809A1 (no) |
EP (1) | EP1385503A1 (no) |
JP (1) | JP2004527551A (no) |
KR (2) | KR20040030609A (no) |
CN (1) | CN1509169A (no) |
AR (1) | AR033308A1 (no) |
AT (1) | AT10974U1 (no) |
BG (1) | BG108379A (no) |
BR (1) | BR0208283A (no) |
CA (1) | CA2445843A1 (no) |
CZ (1) | CZ20033267A3 (no) |
EA (1) | EA200301195A1 (no) |
HR (1) | HRP20030744A2 (no) |
HU (1) | HUP0400054A3 (no) |
IL (1) | IL158031A0 (no) |
IS (1) | IS6954A (no) |
ME (1) | MEP5908A (no) |
MX (1) | MXPA03008777A (no) |
NO (1) | NO20034538L (no) |
PL (1) | PL367480A1 (no) |
SK (1) | SK14612003A3 (no) |
UA (1) | UA82828C2 (no) |
WO (1) | WO2002087566A1 (no) |
YU (1) | YU85303A (no) |
ZA (1) | ZA200307102B (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
JP2004527551A (ja) * | 2001-05-01 | 2004-09-09 | ハー・ルンドベック・アクチエゼルスカベット | エナンチオ純粋なエスシタロプラムの使用方法 |
PL378275A1 (pl) * | 2002-12-23 | 2006-03-20 | H. Lundbeck A/S | Bromowodorek escitalopramu i sposób jego wytwarzania |
US20050037983A1 (en) * | 2003-03-11 | 2005-02-17 | Timothy Dinan | Compositions and methods for the treatment of depression and other affective disorders |
AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
PL1691811T3 (pl) * | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
US20050196453A1 (en) | 2004-03-05 | 2005-09-08 | H. Lundbeck A/S | Crystalline composition containing escitalopram |
EA200601641A1 (ru) * | 2004-03-05 | 2006-12-29 | Х. Лундбекк А/С | Кристаллическая композиция, содержащая оксалат эсциталопрама |
TWI347942B (en) * | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
WO2007048080A2 (en) * | 2005-10-14 | 2007-04-26 | Forest Laboratories, Inc. | Stable pharmaceutical formulations containing escitalopram and bupropion |
US7569605B2 (en) | 2005-10-14 | 2009-08-04 | Forest Laboratories Holdings Limited | Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
CN100353939C (zh) * | 2006-01-05 | 2007-12-12 | 昆明积大制药有限公司 | 含西酞普兰和环糊精的抗抑郁口服药用组合物 |
US20070259952A1 (en) * | 2006-05-02 | 2007-11-08 | H. Lundbeck A/S | Uses of escitalopram |
TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
EP2086509A1 (en) * | 2006-10-20 | 2009-08-12 | Ratiopharm GmbH | Escitalopram and solid pharmaceutical composition comprising the same |
US20100003313A1 (en) * | 2006-10-27 | 2010-01-07 | Hisamitsu Pharmaceutical Co.,Inc. | Adhesive skin patch |
EP2017271A1 (en) | 2007-07-06 | 2009-01-21 | Aurobindo Pharma Limited | Process for the preparation of escitalopram |
KR101612563B1 (ko) * | 2007-08-03 | 2016-04-14 | 리히터 게데온 닐트. | 도파민 수용체 리간드를 함유하는 약학적 조성물 및 도파민 수용체 리간드를 사용한 치료 방법 |
CN101983193B (zh) * | 2008-01-31 | 2014-03-12 | 武田药品工业株式会社 | 注意缺陷/多动障碍的预防或治疗剂 |
ITMI20080768A1 (it) * | 2008-04-24 | 2009-10-25 | Abiogen Pharma Spa | Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one |
WO2010098230A1 (ja) * | 2009-02-27 | 2010-09-02 | 久光製薬株式会社 | 経皮投与製剤 |
US20180071269A1 (en) | 2015-08-12 | 2018-03-15 | Tianxin Wang | Therapeutical methods, formulations and nutraceutical formulations |
WO2016180879A1 (en) * | 2015-05-13 | 2016-11-17 | A. Carlsson Research Ab | Treatment of debilitating fatigue |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143702A (no) * | 1965-03-18 | |||
US4079135A (en) * | 1973-12-13 | 1978-03-14 | Imperial Chemical Industries Limited | Morpholine derivatives as antidepressants |
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB8419963D0 (en) * | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8607313D0 (en) * | 1986-03-25 | 1986-04-30 | Ici Plc | Pharmaceutical compositions |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
US5296507A (en) * | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
US5627196A (en) * | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5554383A (en) * | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
US5747494A (en) * | 1996-06-28 | 1998-05-05 | U C B S.A. | Pharmaceutical compositions for the treatment of depressive disorders |
US5958429A (en) * | 1996-08-16 | 1999-09-28 | Eli Lilly And Company | Potentiation of serotonin response |
ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
US5776969A (en) * | 1997-02-27 | 1998-07-07 | Eli Lilly And Company | Treatment of sleep disorders |
US6069177A (en) * | 1997-07-08 | 2000-05-30 | The Hong Kong University Of Science And Technology | 3-Hydroxy-propanamine derived neuronal reuptake inhibitors |
SE9703375D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
CA2291072C (en) * | 1997-11-11 | 2002-08-20 | H. Lundbeck A/S | Method for the preparation of citalopram |
US6353008B1 (en) * | 1998-06-30 | 2002-03-05 | Eli Lilly And Company | Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
US6150376A (en) * | 1998-08-05 | 2000-11-21 | Georgetown University | Bi- and tri-cyclic aza compounds and their uses |
DK1123284T3 (da) * | 1998-10-20 | 2003-04-28 | Lundbeck & Co As H | Fremgangsmåde til fremstilling af citalopram |
HU227473B1 (en) * | 1999-04-14 | 2011-07-28 | Lundbeck & Co As H | Method for preparation of citalopram |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
US6333357B1 (en) * | 1999-11-05 | 2001-12-25 | Be Able, Llc | Behavior chemotherapy |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
WO2001080845A2 (en) * | 2000-04-24 | 2001-11-01 | Aryx Therapeutics | (2-aminoethyl) oxime derivatives for the treatment of depression |
JP2004527551A (ja) * | 2001-05-01 | 2004-09-09 | ハー・ルンドベック・アクチエゼルスカベット | エナンチオ純粋なエスシタロプラムの使用方法 |
-
2002
- 2002-05-01 JP JP2002584912A patent/JP2004527551A/ja active Pending
- 2002-05-01 UA UA2003098415A patent/UA82828C2/xx unknown
- 2002-05-01 YU YU85303A patent/YU85303A/sh unknown
- 2002-05-01 KR KR10-2003-7014286A patent/KR20040030609A/ko active Application Filing
- 2002-05-01 SK SK1461-2003A patent/SK14612003A3/sk not_active Application Discontinuation
- 2002-05-01 HU HU0400054A patent/HUP0400054A3/hu unknown
- 2002-05-01 US US10/468,685 patent/US20040198809A1/en not_active Abandoned
- 2002-05-01 IL IL15803102A patent/IL158031A0/xx unknown
- 2002-05-01 WO PCT/DK2002/000281 patent/WO2002087566A1/en active Application Filing
- 2002-05-01 EA EA200301195A patent/EA200301195A1/ru unknown
- 2002-05-01 MX MXPA03008777A patent/MXPA03008777A/es unknown
- 2002-05-01 CA CA002445843A patent/CA2445843A1/en not_active Abandoned
- 2002-05-01 CN CNA028092309A patent/CN1509169A/zh active Pending
- 2002-05-01 CZ CZ20033267A patent/CZ20033267A3/cs unknown
- 2002-05-01 KR KR1020097027003A patent/KR20100012089A/ko not_active Application Discontinuation
- 2002-05-01 PL PL02367480A patent/PL367480A1/xx not_active Application Discontinuation
- 2002-05-01 EP EP02724141A patent/EP1385503A1/en not_active Withdrawn
- 2002-05-01 BR BR0208283-7A patent/BR0208283A/pt not_active IP Right Cessation
- 2002-05-01 ME MEP-59/08A patent/MEP5908A/xx unknown
- 2002-05-02 AR ARP020101612A patent/AR033308A1/es unknown
-
2003
- 2003-08-20 US US10/644,579 patent/US20040192765A1/en not_active Abandoned
- 2003-08-20 US US10/644,576 patent/US20040192764A1/en not_active Abandoned
- 2003-08-20 US US10/644,588 patent/US20040192766A1/en not_active Abandoned
- 2003-08-20 US US10/644,577 patent/US20040198810A1/en not_active Abandoned
- 2003-08-20 US US10/644,587 patent/US20040198811A1/en not_active Abandoned
- 2003-09-11 ZA ZA200307102A patent/ZA200307102B/xx unknown
- 2003-09-15 IS IS6954A patent/IS6954A/is unknown
- 2003-09-16 HR HR20030744A patent/HRP20030744A2/xx not_active Application Discontinuation
- 2003-10-09 NO NO20034538A patent/NO20034538L/no not_active Application Discontinuation
- 2003-11-24 BG BG108379A patent/BG108379A/bg unknown
-
2007
- 2007-09-12 US US11/853,949 patent/US20080004338A1/en not_active Abandoned
-
2008
- 2008-03-21 AT AT0017508U patent/AT10974U1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20100012089A (ko) | 2010-02-05 |
US20040192766A1 (en) | 2004-09-30 |
AR033308A1 (es) | 2003-12-10 |
US20040192765A1 (en) | 2004-09-30 |
BG108379A (bg) | 2004-11-30 |
US20040198810A1 (en) | 2004-10-07 |
CN1509169A (zh) | 2004-06-30 |
WO2002087566A1 (en) | 2002-11-07 |
YU85303A (sh) | 2006-05-25 |
AT10974U1 (de) | 2010-02-15 |
US20080004338A1 (en) | 2008-01-03 |
US20040198809A1 (en) | 2004-10-07 |
UA82828C2 (en) | 2008-05-26 |
CA2445843A1 (en) | 2002-11-07 |
IL158031A0 (en) | 2004-03-28 |
IS6954A (is) | 2003-09-15 |
US20040198811A1 (en) | 2004-10-07 |
KR20040030609A (ko) | 2004-04-09 |
CZ20033267A3 (en) | 2004-06-16 |
US20040192764A1 (en) | 2004-09-30 |
EA200301195A1 (ru) | 2004-04-29 |
MEP5908A (xx) | 2010-02-10 |
EP1385503A1 (en) | 2004-02-04 |
ZA200307102B (en) | 2004-09-13 |
HUP0400054A2 (hu) | 2004-04-28 |
HRP20030744A2 (en) | 2005-06-30 |
JP2004527551A (ja) | 2004-09-09 |
NO20034538L (no) | 2003-10-09 |
SK14612003A3 (sk) | 2004-04-06 |
BR0208283A (pt) | 2004-03-09 |
PL367480A1 (en) | 2005-02-21 |
HUP0400054A3 (en) | 2007-03-28 |
MXPA03008777A (es) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034538L (no) | Anvendelsen av enantiomer ren escitalopram | |
NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
NO20031494D0 (no) | Bestemmelse av brudd-lukningstrykk | |
DE60202737D1 (de) | Kappenanordnung | |
IS6971A (is) | Ný efnasambönd | |
NO20011272L (no) | Fremgangsmåte for fremstilling av ren citalopram | |
NO20011271A (no) | Fremgangsmåte for fremstilling av ren citalopram | |
BR0201972B1 (pt) | montante de suspensão. | |
NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
LU91603I2 (fr) | Eslicarbazepine acetate (Zebinix - eslicarbazepineacetate) Composé: énantiomère S de la Licarbazepi ne | |
NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
DE60224290D1 (de) | Herstellung von metallrohren | |
NO20042667L (no) | Fremgangsmate for fremstilling av escitalopram | |
DE50212400D1 (de) | Lastschaltbare Mehrgangnabe | |
ATE286478T1 (de) | Verschlusskappe | |
NO20041200L (no) | Fremgangsmate for fremstilling av citalopram. | |
NO20041968L (no) | Anvendelse av cystationin | |
NO20042613L (no) | Ny anvendelse for behandling av gastroosofagial refluks | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
DE60126053D1 (de) | Applikator | |
EE200400016A (et) | Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks | |
ATA922001A (de) | Vorsatzschale | |
DE50203590D1 (de) | Applikator | |
DE50204437D1 (de) | Borstenbremsring | |
UA5955S (uk) | Комбінований ковпачок |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |